NCT03909230 is a clinical trial in Endometrial Fluid, sponsored by Anecova SA.

Who is sponsoring NCT03909230?

NCT03909230 is sponsored by Anecova SA.

What condition does NCT03909230 study?

NCT03909230 studies Endometrial Fluid.

Is NCT03909230 still recruiting?

NCT03909230 is currently completed. Last updated 18 March 2021.

Last reviewed 2021-03-18 · How we verify

NCT03909230

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Endometrial Fluid Study in Natural Cycles: a Prospective Observational Study

Completed Last updated 18 March 2021

What this trial tests

trial in Endometrial Fluid in 30 participants. Completed in 27 May 2019.

Timeline

2 April 2019

Primary endpoint
27 May 2019

27 May 2019

Quick facts

Lead sponsor	Anecova SA
Status	Completed
Study type	OBSERVATIONAL
Enrollment	30
Start date	2 April 2019
Primary completion	27 May 2019
Estimated completion	27 May 2019
Sites	1 location across Spain

Conditions studied

Endometrial Fluid — all drugs for Endometrial Fluid →

Sponsor

Anecova SA

Who can join

Under 35, female only, with Endometrial Fluid. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is designed to collect information about the characteristics of endometrial fluid at day 2 and day 4 post-ovulation in normal fertile women.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Anecova SA trials

Trials by the same sponsor.

NCT03191890 — Post Market Surveillance & Post Market Clinical Follow up, International, Medical Registry to Confirm the Safety and the · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03909230 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Anecova SA
Last refreshed: 18 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03909230.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing